Pancreatic Cancer Research

ResearcherStavanger University HospitalActive in the last 2 years

Karin Hestnes Edland

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4212-803X; OpenAlex author ID A5060056146. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. Malpractice claims for pancreatic cancer in Norway: claim-rates, injury domains, claim outcomes and indemnity compensation. First author DOI 10.2340/ao.v65.45500↗
  2. Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragm… Co-author DOI 10.1002/1878-0261.70116↗
  3. Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiol… Co-author DOI 10.1002/1878-0261.13472↗
  4. Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer. First author DOI 10.1158/1078-0432.ccr-22-3526↗
  5. Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study. Co-author DOI 10.1186/s12885-022-09714-x↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kjersti Tjensvoll · 4 shared papers, 2022–2025 · strength 0.75
  2. Bjørnar Gilje · 4 shared papers, 2022–2025 · strength 0.75
  3. Morten Lapin · 4 shared papers, 2022–2025 · strength 0.75
  4. Oddmund Nordgård · 4 shared papers, 2022–2025 · strength 0.75
  5. Annbjørg Hegelstad Søreide · 1 shared paper, 2026 · strength 0.39
  6. Kjetil Søreide · 1 shared paper, 2026 · strength 0.39
  7. Rune Smaaland · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.